AbbVie (ABBV) Assets (2012 - 2026)
AbbVie's Assets was $135.12 billion in Q2 2026, down 1.5% from $137.18 billion a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Assets at AbbVie came in at $133.96 billion, down 0.9% from FY2024.
- Assets shows a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- In earlier years, Assets was $135.16 billion in FY2024 (+0.3%), $134.71 billion in FY2023 (-2.9%), $138.81 billion in FY2022 (-5.3%) and $146.53 billion in FY2021 (-2.7%).
- Quarterly Assets has moved between $133.9 billion (Q3 2025) and $148.87 billion (Q1 2024) over five years.
- Compared with a year earlier, Assets was higher in three of the last eight quarters, with an average decline of 1.9%.
- The best year-over-year quarter for Assets over five years was Q1 2024 (growth of 10.7%); the worst was Q1 2025 (a decline of 8.5%).
- Per Business Quant data, ABBV's Assets in the three quarters before Q2 2026 was $136.46 billion (Q1 2026), $133.96 billion (Q4 2025) and $133.9 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 87.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 135.12 Bn |
| Mar 31, 2026 | 136.46 Bn |
| Dec 31, 2025 | 133.96 Bn |
| Sep 30, 2025 | 133.90 Bn |
| Jun 30, 2025 | 137.18 Bn |
| Mar 31, 2025 | 136.17 Bn |
| Dec 31, 2024 | 135.16 Bn |
| Sep 30, 2024 | 143.42 Bn |
| Jun 30, 2024 | 141.94 Bn |
| Mar 31, 2024 | 148.87 Bn |
| Dec 31, 2023 | 134.71 Bn |
| Sep 30, 2023 | 136.22 Bn |
| Jun 30, 2023 | 135.37 Bn |
| Mar 31, 2023 | 134.54 Bn |
| Dec 31, 2022 | 138.81 Bn |
| Sep 30, 2022 | 141.33 Bn |
| Jun 30, 2022 | 143.19 Bn |
| Mar 31, 2022 | 143.21 Bn |
| Dec 31, 2021 | 146.53 Bn |
| Sep 30, 2021 | 148.86 Bn |
API Access
AbbVie Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();